INTR
Inter & Co. Inc. Class A Common Shares
Mentions (24Hr)
0.00% Today
Reddit Posts
$INTR: The Brazilian "Super App" Powerhouse. Why I just started a dedicated community for Inter&Co
3 High‑Growth Stocks I Think Are MASSIVELY Undervalued (March 2026) (growing 50-100%/y)
Financial Services Stocks Moving Wednesday: UIHC, CIFR, LX, CACC, INTR, BFH, CB, ORGNW
Financial Services Stocks Moving Wednesday: UIHC, CIFR, LX, CACC, INTR, BFH, CB, ORGNW
Mentions
**BanBet Created** ▲ | **Record:** 1W - 1L | Ticker | Target | Entry | Move | Expires | |:---:|:---:|:---:|:---:|:---:| | **INTR** | $5.92 (above) | $5.38 | +10.0% | Sep 20, 12:54 AM |
!banbet INTR +10% 3w
!banbet INTR +10% 4w
!banbet INTR +10% 4w
Upon some research I found INTR. Benefits and revenues skyrocketting since they introduced loan on salary. Valuation seems to good to be true by every metric. Am I missing something?
NVDA, AMZN, DAVE, META, JNJ, INTR, TRX are some of my holdings. Sold all my MSFT after the run up.
# Calls on: * BSX * DIS * KO * RDW * LUNR * IONQ * INTR * ARRY * DASH >***AFTER HOURS volume tells you the future***
I have rotated some into NU, INTR and NICE. I believe all three are undervalued.
lol what about $INTR? 😂
Agreed on valuation. Thoughts on INTR?
Compounding business with increasing revenue and earnings growth traded at a modest valuation (PEG below 1). Uber, nvidia, NU, INTR, MELI, adobe, expedia, reddit, meta, BN among others
NU, INTR, & WIT , WMT today . and Sony next week.
NU INTR and SOFI are all great longs. NU and INTR are both down because of the Brazil default problems, but they are not overly exposed to bad loans so should do quite well longterm
Question: what advantages does INTR have over STNE and PAGS?
Caught these falling knives: GOOG, HOOD, CRWD, AMZN, INTR, TMO, PGR
INTR is another good one and competes directly with NU in Brazil. A little better valuation and PEG than NU but I like, and own, both
I dont touch medical, insurance nor real estate etc, as I dont understand those industries. So a lot of stocks that get mentioned here are an immediate no for me. I work in tech/semiconductor space, and even tho I follow my industry pretty closely, I still for example found ONTO and CAMT thanks to this sub. Also, I often invest in fintech as my brother works in that industry, so I run some of my picks through him too. And SEZL and DAVE I found thanks to this sub. Also NU and INTR as nice diversification plays for South America. All of these did quite well, and I still hold them. As I said, I combed through probably 100s of stocks on such posts (here and valueinvesting sub) and only picked a couple. Obviously, looking at stocks here, or listening to what folks have to say, is not an investment advice. You should always develop and do your own due diligence.
Hahaha sim. Eu tbm invisto por la!! Go INTR!!!
>If he's going to sell calls on unh I'd sell them itm as a way to exit. Selling calls in general is a losing strategy. I'd avoid it as much as possible but if he decides he wants to I'd agree. >I think target and wal mart are both going to be in some pain in the months ahead. Consumer debt really can't handle much more pressure and consumer confidence is just not there. That's why I suggested a long TGT/short WMT trade. WMT is near its highs on declining margins w/ meager growth. Target has seen a small drop in revenue but if the consumer is tapping out both will see a decline and WMT is likely to fall much more given the sky high valuation. TGT doesn't look terrible here as a long on fundamentals but the consumer is certainly shaky. That being said, the stock is down almost 40% since the election, so it would appear that is being priced in to an extent. Either way absolutely a long relative to WMT imo given similar consumer exposure and diverging valuations >I also wouldn't touch LLY or most biotech, especially right now, due to its reliance on medical trials. Unless you can properly hedge the downside or take a defined risk position that you're comfortable with. The hedge to the downside risk is the valuation of these companies. Your view is the consensus: don't touch biotech. Hence why XBI is at 2017 levels. I've found that when everyone can agree directionally on something it tends to be mispriced. That being said I agree that any single early stage biotech name has massive binary risk. The sector as a whole has immense uncertainty surrounding it and given historically low valuations is a reasonable sector to consider a position in for a swing in sentiment. >Mercado Libre is worth noting though since you talked about Mexico and Latin America. Agree this will probably do well on LatAm flows but I'm not a fan of the valuation -- valued like a US company in a LatAM market and feel there are much more compelling options if one wants to choose a single name in Brazil. I'd rather own something like INTR at 16x trailing earnings w/ similar revenue growth to MELI and a larger growth runway
Coupd you check INTR please, u/RyanEvansAFT? Ty!!
I think countries in the region will start looking to Brazil as tensions with the U.S. escalate. I’m long on ABEV and INTR.
INTR Brazilian FinTech, I think South America is gonna be getting juicy in the poosy in the next year or two.
Whats the analysis on INTR
For Brazilian banks look into NU and INTR, NU has been performing very well the last few years. I think INTR is still a very good company which took a beating recently due to macro economics
I’m watching INTR right now which took a beating recently even though their revenue has been consistently been going up
Itaú and Banco do Brasil are higher than they were in 2019’s high. The main problem with their performance was not the bank itself, but higher interest rates that pushed valuations lower. Itaú’s clients are of a higher networth on average and Banco do Brasil is heavily invested in agriculture, most of our farmers take credit only with Banco do Brasil. Santander and Bradesco are a different story, a lot of delinquency rates and provisions for bad debt. You are right about NU having fewer costs than Bradesco and other banks, but NU valuation is also way more expensive and with a more difficult and less obvious path for growth. Nubank’s clients are the basis of the piramid here in Brazil, we commonly say it’s the bank of “interns and poor people”. With that said, I think it’s a great business long term, but I think it may see a major decline in price next year. INTR is way less expensive and is growing fast, I have them as my favourites.
Do you all like INTR as well in addition to NU?
Brazilian here, can attest that everyone uses this bank around here. I personally lost some money buying its IPO, and competition is strong and arguably better, like Inter (INTR). I use both.
Historically doesn’t the crash come AFTER INTR EST RATES NORMALIZE?
Just buy INTR, 1,8 BI MC vs 35 BI Buffett's Nubank
Brazilian financials $XP and $INTR both did well and are up afterhours. Gives me hope for $STNE and $PAGS CC: /u/mambabfk
INTR its my biggest win this year... Warren Buffer' Nu competidor, so far so good
The Nasdaq's newborn INTR is up 7% today, it is up from its ATH and is a promising broker and digital bank, the one that I use actually.